A detailed history of Oversea Chinese Banking Corp LTD transactions in Biogen Inc. stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 15,742 shares of BIIB stock, worth $2.36 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,742
Previous 12,597 24.97%
Holding current value
$2.36 Million
Previous $2.92 Million 4.49%
% of portfolio
0.09%
Previous 0.09%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$189.07 - $236.8 $594,625 - $744,736
3,145 Added 24.97%
15,742 $3.05 Million
Q2 2024

Aug 05, 2024

BUY
$190.52 - $236.72 $3,048 - $3,787
16 Added 0.13%
12,597 $2.92 Million
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $171,948 - $217,112
811 Added 6.89%
12,581 $2.71 Million
Q4 2023

May 21, 2024

SELL
$222.59 - $267.94 $180,520 - $217,299
-811 Reduced 6.45%
11,770 $3.05 Million
Q4 2023

Jan 31, 2024

BUY
$222.59 - $267.94 $166,942 - $200,955
750 Added 6.81%
11,770 $3.05 Million
Q3 2023

Apr 29, 2024

SELL
$253.3 - $285.89 $189,975 - $214,417
-750 Reduced 6.37%
11,020 $2.83 Million
Q3 2023

Nov 03, 2023

BUY
$253.3 - $285.89 $347,021 - $391,669
1,370 Added 14.2%
11,020 $2.83 Million
Q1 2023

Sep 15, 2023

BUY
$256.56 - $292.34 $56,443 - $64,314
220 Added 2.33%
9,650 $2.68 Million
Q1 2023

May 08, 2023

BUY
$256.56 - $292.34 $56,443 - $64,314
220 Added 2.33%
9,650 $2.68 Million
Q4 2022

Sep 15, 2023

SELL
$252.44 - $306.72 $55,536 - $67,478
-220 Reduced 2.28%
9,430 $2.61 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $2.38 Million - $2.89 Million
9,430 New
9,430 $0

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.